1. Home
  2. ETD vs PHAR Comparison

ETD vs PHAR Comparison

Compare ETD & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETD
  • PHAR
  • Stock Information
  • Founded
  • ETD 1932
  • PHAR 1988
  • Country
  • ETD United States
  • PHAR Netherlands
  • Employees
  • ETD N/A
  • PHAR N/A
  • Industry
  • ETD Home Furnishings
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETD Consumer Discretionary
  • PHAR Health Care
  • Exchange
  • ETD Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • ETD 692.5M
  • PHAR 718.1M
  • IPO Year
  • ETD 1993
  • PHAR N/A
  • Fundamental
  • Price
  • ETD $29.33
  • PHAR $10.69
  • Analyst Decision
  • ETD Hold
  • PHAR Strong Buy
  • Analyst Count
  • ETD 2
  • PHAR 3
  • Target Price
  • ETD $30.00
  • PHAR $30.00
  • AVG Volume (30 Days)
  • ETD 250.0K
  • PHAR 4.6K
  • Earning Date
  • ETD 07-30-2025
  • PHAR 07-31-2025
  • Dividend Yield
  • ETD 6.69%
  • PHAR N/A
  • EPS Growth
  • ETD N/A
  • PHAR N/A
  • EPS
  • ETD 2.25
  • PHAR N/A
  • Revenue
  • ETD $622,924,000.00
  • PHAR $320,708,000.00
  • Revenue This Year
  • ETD N/A
  • PHAR $13.31
  • Revenue Next Year
  • ETD $0.96
  • PHAR $7.68
  • P/E Ratio
  • ETD $13.02
  • PHAR N/A
  • Revenue Growth
  • ETD N/A
  • PHAR 24.13
  • 52 Week Low
  • ETD $24.55
  • PHAR $6.65
  • 52 Week High
  • ETD $35.62
  • PHAR $12.61
  • Technical
  • Relative Strength Index (RSI)
  • ETD 67.59
  • PHAR 49.53
  • Support Level
  • ETD $27.35
  • PHAR $10.41
  • Resistance Level
  • ETD $28.43
  • PHAR $11.49
  • Average True Range (ATR)
  • ETD 0.67
  • PHAR 0.36
  • MACD
  • ETD 0.22
  • PHAR -0.12
  • Stochastic Oscillator
  • ETD 85.05
  • PHAR 29.68

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: